From one side, IGF2 showed no predictive value in ACC [10] and no correlation with clinicopathological, biological, and transcriptomic features [10, 11, 16] as well as relapse, metastasis and survival [10, 11]. This evidence concerns the gene IGF2 and adrenal cortex carcinoma.